Our Services
Tailored regulatory guidance for life sciences companies navigating complex markets.
Global Regulatory Strategy & Submission Management
We develop comprehensive regulatory roadmaps for life science entities and medical device manufacturers seeking market access in the U.S. and the Asia-Pacific region.
Strategic FDI Advisory
Expert advisory on Foreign Direct Investment (FDI) for life science entities looking to establish physical operations (factories or R&D centers) in the U.S. or China.
We design and implement robust Quality Management Systems (QMS) that satisfy global Good Practice (GxP) standards. We prepare firms for unannounced inspections and lead internal compliance audits to identify and remediate regulatory gaps.
Compliance & GxP Quality Auditing
Strategic Partnership: Shandong Tianli Pharmaceutical Co., Ltd.
Life Science Compliance LLC serves as the primary U.S. regulatory and legal liaison for Shandong Tianli Pharmaceutical Co., Ltd., a global leader in biochemical manufacturing with $600M in annual revenue. Our firm provides comprehensive advisory services to support the strategic entry and expansion of Tianli’s Ascorbic Acid (Vitamin C) and Polyol product lines within the United States market.
Our Services include:
U.S. Market Entry Strategy: Conducting intensive market surveys and regulatory gap analysis to align Tianli’s global production standards with FDA pharmaceutical and food-grade requirements.
Inbound Investment Feasibility: Evaluating the logistical and legal feasibility of establishing U.S.-based infrastructure (factories and specialized warehousing) to optimize the North American supply chain and reduce "landed" costs.
Cross-Border Regulatory Mapping: Navigating the intersection of U.S. Trade Law and China’s NMPA standards to ensure seamless international data integrity and product certification.
Contact
Reach us for tailored compliance counsel.
© 2026. All rights reserved.